| Patent | Date |
|---|
Combination preparations comprising bifeprunox and a dopamine agonist
Grant 8,106,056 - McCreary , et al. January 31, 2 | 2012-01-31 |
Phenylpiperazine derivatives with a combination of partial dopamine-D.sub.2 receptor agonism and serotonin reuptake inhibition
Grant 8,101,619 - Feenstra , et al. January 24, 2 | 2012-01-24 |
Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
Grant 8,067,603 - Den Hartog , et al. November 29, 2 | 2011-11-29 |
Combination preparations comprising SLV308 and a dopamine agonist
Grant 7,915,262 - McCreary , et al. March 29, 2 | 2011-03-29 |
Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
Grant 7,851,630 - Den Hartog , et al. December 14, 2 | 2010-12-14 |
Combination Preparations Comprising Slv308 And A Dopamine Agonist
App 20100292248 - McCreary; Andrew C. ; et al. | 2010-11-18 |
Combination preparations comprising SLV308 and a dopamine agonist
Grant 7,786,126 - McCreary , et al. August 31, 2 | 2010-08-31 |
N-oxides as prodrugs of piperazine and piperidine derivatives
Grant 7,750,013 - Koopman , et al. July 6, 2 | 2010-07-06 |
[1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and NADPH quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
Grant 7,678,789 - Feenstra , et al. March 16, 2 | 2010-03-16 |
Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
Grant 7,596,407 - Bouwstra , et al. September 29, 2 | 2009-09-29 |
Compositions, Kits and Methods for a Titration Schedule for Pardoprunox Compounds
App 20090215796 - Bronzova; Juliana B. ; et al. | 2009-08-27 |
Combination Preparations Comprising Slv308 And A Dopamine Agonist
App 20070293505 - McCREARY; Andrew C. ; et al. | 2007-12-20 |
Combination Preparations Comprising Bifeprunox And A Dopamine Agonist
App 20070293506 - McCREARY; Andrew C. ; et al. | 2007-12-20 |
Piperazine and piperidine compounds
Grant 7,297,699 - Feenstra , et al. November 20, 2 | 2007-11-20 |
Hexa- and octahydro-pyrido[1,2-a]pyrazine derivatives with NK.sub.1 antagonistic activity
Grant 7,244,734 - Iwema Bakker , et al. July 17, 2 | 2007-07-17 |
Phenypiperazine Derivatives With A Combination Of Partial Dopamine-d2 Receptor Agonism And Serotonin Reuptake Inhibition
App 20070142397 - Feenstra; Roelof W. ; et al. | 2007-06-21 |
Diazabicyclo alkane derivatives with NK.sub.1 antagonistic activity
Grant 7,202,238 - de Boer , et al. April 10, 2 | 2007-04-10 |
N-oxides as prodrugs of piperazine and piperidine derivatives
App 20070043059 - Koopman; Theodorus S.M. ; et al. | 2007-02-22 |
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
App 20060247256 - Feenstra; Roelof W. ; et al. | 2006-11-02 |
[1,2,4]-Dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and NADPH quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
App 20060194846 - Feenstra; Roelof W. ; et al. | 2006-08-31 |
Piperazine oxime dervatives having NK-1 receptor antagonistic activity
Grant 7,094,779 - Bakker , et al. August 22, 2 | 2006-08-22 |
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
App 20060122190 - Feenstra; Roelof W. ; et al. | 2006-06-08 |
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
App 20060122189 - Feenstra; Roelof W. ; et al. | 2006-06-08 |
New piperazine and piperidine compounds
App 20060089366 - Feenstra; Roelof W. ; et al. | 2006-04-27 |
1-[2H-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain
App 20050215567 - Bakker, Cornelis ; et al. | 2005-09-29 |
1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders
App 20050215551 - Bakker, Cornelis ; et al. | 2005-09-29 |
Piperazine and piperidine compounds
Grant 6,911,448 - Feenstra , et al. June 28, 2 | 2005-06-28 |
Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
App 20050075355 - Den Hartog, Jacobus A.J. ; et al. | 2005-04-07 |
Hexa-and octahydro-pyrido[1,2-a]pyrazine derivatives with NK1 antagonistic activity
App 20050070548 - Iwema Bakker, Wouter I. ; et al. | 2005-03-31 |
Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
App 20050070528 - Den Hartog, Jacobus A.J. ; et al. | 2005-03-31 |
Phenylpiperazines
Grant 6,828,325 - Feenstra , et al. December 7, 2 | 2004-12-07 |
Vaccines with an LTB adjuvant
Grant 6,793,928 - van Scharrenburg , et al. September 21, 2 | 2004-09-21 |
Piperazine oxime dervatives having nk-1 receptor antagonistic activity
App 20040176389 - Bakker, Wouter I Ivema ; et al. | 2004-09-09 |
Piperazine and piperidine compounds
Grant 6,780,864 - Feenstra , et al. August 24, 2 | 2004-08-24 |
Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
App 20030186838 - Feenstra, Roelof W. ; et al. | 2003-10-02 |
| 